8 Results for "

MSI-H

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "MSI-H" in MCE Product Catalog:

Cat. No.: HY-169422
CAS No.: 3064599-36-3
Synonyms: IDE275
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

GSK4418959 (IDE275) is a selective, reversible and orally active WRN helicase inhibitor. GSK4418959 shows >10,000-fold selectivity over other helicases. GSK4418959 inhibits ATPase and DNA unwinding functions in an ATP-competitive manner. GSK4418959 can be used for the study of microsatellite instability-high (MSI-H) cancer, such as colorectal cancer (CRC) and endometrial cancer (EC) .
loading...
    loading...
Cat. No.: HY-169422A
CAS No.: 3064599-37-4
Synonyms: IDE275 (enantiomer)
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

GSK4418959 enantiomer is an enantiomer of GSK4418959 (HY-169422). GSK4418959 (IDE275) is a non-covalent, reversible, selective and orally active WRN helicase inhibitor. GSK4418959 inhibits ATPase and DNA unwinding functions in an ATP-competitive manner. GSK4418959 can be used for the study of microsatellite instability-high (MSI-H) cancer .
loading...
    loading...
Cat. No.: HY-174217
CAS No.: 3058652-58-4
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN-IN-19 (Compound (S)-27) is a covalent WRN helicase inhibitor, with pIC50 (0 h/4 h) = 5.4/7.5 in the DNA-unwinding 5 endpoint assays. WRN-IN-19 shows synthetic lethality in MSI-H (high microsatellite instability) cancer cells .
loading...
    loading...
Cat. No.: HY-178474
CAS No.: 3095277-20-3
Research Areas:  

Cancer

WRN inhibitor 20 (Compound 14c) is a WRN degradation agent. WRN inhibitor 20 exhibits strong degradation activity in various cells, such as HCT-116 (DC50 = 1.7 µM), SW-48 (DC50 = 3.0 µM), and SW-480 (DC50 = 5.9 µM) cells. WRN inhibitor 20 exhibits potent anti proliferative, pro apoptotic, migration inhibiting, and DNA damage inducing effects in MSI-H cells. WRN inhibitor 20 can be used for research on cancer .
loading...
    loading...
Cat. No.: HY-176912
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN-IN-22 (compound A01) is a potent Werner syndrome RecQ helicase (WRN) inhibitor (IC50 < 100 nM). WRN-IN-22 can be used for microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancer research, such as colorectal, gastric, prostate and endometrial cancer .
loading...
    loading...
Cat. No.: HY-183610
CAS No.: 3059172-54-9
Target:  

DNA/RNA Synthesis PAK

Research Areas:  

Cancer

WRN-IN-26 is an orally active Werner syndrome helicase (WRN) inhibitor with a human Ki value of 58.7 μM and an IC50 value of 0.026 μM. WRN-IN-26 selectively targets the cysteine residues of WRN. WRN-IN-26 induces the expression of p21 protein in MSI-H tumor cells. WRN-IN-26 inhibits the growth of MSI-H tumor cells and exhibits potent in vivo efficacy in MSI-H xenograft tumor models. WRN-IN-26 can be used for the research of microsatellite instability-high (MSI-H) cancers .
loading...
    loading...
Cat. No.: HY-189009
CAS No.: 3112500-81-6
Target:  

DNA/RNA Synthesis PAK

Research Areas:  

Cancer

WC-2 is an ATP-competitive covalent WRN helicase inhibitor with IC50 values of 252 nM and 250 nM. WC-2 binds covalently to Cys727 of WRN helicase and maintains conformational complementarity with this protein. WC-2 induces p21 transcription as part of the DNA damage response, and selectively reduces the viability of MSI-H cancer cells. WC-2 can be used in the research of MSI-H tumors .
loading...
    loading...
Cat. No.: HY-184427
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN-IN-27 is a potent, selective and orally active Werner syndrome RecQ helicase (WRN) inhibitor. WRN-IN-27 inhibits WRN with IC50 values of 20.0 nM and 43.2 nM in the ADP-Glo kinase assay and fluorometric helicase assay, respectively. WRN-IN-27 inhibits MSI-H cell growth selectively (GI50 = 61.8-440 nM), and exhibits antitumor activity in the colon cancer model for MSI-H tumor research .
loading...
    loading...